Related Experiment Videos
IL-1 beta and IL-3-like activity in preterm infants
1Haematology Research Laboratory, Hasharon Hospital, Golda Medical Centre, Tel Aviv University Medical School, Petah-Tiqva, Israel.
Clinical and Experimental Immunology
|February 1, 1993
Summary
Preterm neonates show reduced capacity for releasing IL-1 beta and IL-3-like activity (IL-3-LA). This impaired immune response may contribute to their increased susceptibility to infections.
Area of Science:
- Immunology
- Neonatal Health
- Hematopoiesis
Background:
- Preterm neonates exhibit unique immunological profiles compared to full-term infants and adults.
- Interleukin-1 beta (IL-1 beta) and IL-3-like activity (IL-3-LA) are crucial cytokines involved in immune responses and hematopoiesis.
Purpose of the Study:
- To investigate the capacity of peripheral blood mononuclear cells (PBMC) from preterm neonates to release IL-1 beta and IL-3-LA.
- To compare this capacity with that of maternal and adult controls.
- To assess the influence of preterm serum on PBMC cytokine production.
Main Methods:
- Isolation and culture of peripheral blood mononuclear cells (PBMC) from preterm neonates, their mothers, and adult controls.
- Measurement of IL-1 beta and IL-3-like activity (IL-3-LA) released by PBMC.
- Incubation of adult control PBMC with preterm, maternal, and adult sera to evaluate serum effects.
Main Results:
- PBMC from preterm neonates demonstrated significantly lower release of IL-1 beta and IL-3-LA compared to maternal and adult controls.
- Preterm serum exhibited reduced stimulatory effects on IL-1 beta production and inhibitory effects on IL-3-LA secretion by adult PBMC.
Conclusions:
- Preterm neonates have an impaired capacity for cytokine release, potentially affecting immune function.
- Serum factors in preterm infants may modulate immune cell activity, suggesting a feedback mechanism in hematopoiesis.
- Reduced IL-1 beta and IL-3-LA production may underlie the heightened susceptibility to infections observed in preterm newborns.